Santen Pharmaceutical (SNPHY) Short Interest Ratio & Short Volume $9.88 +0.22 (+2.22%) (As of 12/20/2024 05:55 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartFinancialsSEC FilingsShort Interest Santen Pharmaceutical Short Interest DataSanten Pharmaceutical (SNPHY) has a short interest of 100 shares. This marks a ∞ increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 7,208 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest0 sharesChange Vs. Previous Month+∞Dollar Volume Sold Short$1,061.00Short Interest Ratio0.0 Days to CoverLast Record DateNovember 30, 2024Today's Trading Volume5,891 sharesAverage Trading Volume7,208 sharesToday's Volume Vs. Average82% Short Selling Santen Pharmaceutical? Sign up to receive the latest short interest report for Santen Pharmaceutical and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSNPHY Short Interest Over TimeSNPHY Days to Cover Over TimeSNPHY Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Santen Pharmaceutical Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/2024100 shares $1,061.00 No ChangeN/A0 $10.61 10/31/2024100 shares $1,184.00 -85.7%N/A0 $11.84 10/15/2024700 shares $8,442.00 -12.5%N/A0.3 $12.06 9/30/2024800 shares $10,124.00 -57.9%N/A0.1 $12.66 9/15/20241,900 shares $24,348.50 -17.4%N/A0.5 $12.82 8/31/20242,300 shares $28,508.50 +4.6%N/A1 $12.40 Get the Latest News and Ratings for SNPHY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Santen Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. 8/15/20242,200 shares $26,554.00 +15.8%N/A0.1 $12.07 7/31/20241,900 shares $22,325.00 -24.0%N/A0 $11.75 7/15/20242,500 shares $28,175.00 -3.9%N/A1.9 $11.27 6/30/20242,600 shares $26,520.00 -10.3%N/A0.2 $10.20 6/15/20242,900 shares $29,717.75 +383.3%N/A0.8 $10.25 5/31/2024600 shares $6,160.20 No ChangeN/A0.3 $10.27 4/30/2024100 shares $994.00 No ChangeN/A0 $9.94 4/15/2024100 shares $912.00 No ChangeN/A0 $9.12 3/31/2024100 shares $975.00 No ChangeN/A0.1 $9.75 3/15/2024100 shares $982.42 -99.5%N/A0 $9.82 2/29/202420,800 shares $204,464.00 +20,700.0%N/A0.7 $9.83 2/15/2024100 shares $1,001.00 No ChangeN/A0 $10.01 1/15/2024100 shares $1,014.00 No ChangeN/A0.1 $10.14 11/30/2023900 shares $8,595.45 +80.0%N/A0.4 $9.55 11/15/2023500 shares $4,490.00 +400.0%N/A0.1 $8.98 10/31/2023100 shares $868.50 -85.7%N/A0 $8.69 10/15/2023700 shares $6,204.45 -41.7%N/A0.3 $8.86 9/30/20231,200 shares $10,944.00 -64.7%N/A0.3 $9.12 9/15/20233,400 shares $32,878.00 -30.6%N/A2.1 $9.67 8/31/20234,900 shares $45,300.50 +36.1%N/A1.5 $9.25 8/15/20233,600 shares $33,588.00 -52.6%N/A0.4 $9.33 7/31/20237,600 shares $65,664.00 +216.7%N/A1.4 $8.64 7/15/20232,400 shares $20,040.00 +242.9%N/A0.3 $8.35 6/30/2023700 shares $5,908.00 +16.7%N/A0 $8.44 6/15/2023600 shares $5,100.00 +100.0%N/A0.1 $8.50 5/31/2023300 shares $2,742.00 -25.0%N/A0.2 $9.14 5/15/2023400 shares $3,624.00 No ChangeN/A0.2 $9.06 4/15/2023400 shares $3,296.00 +100.0%N/A0.1 $8.24 3/31/2023200 shares $1,694.00 -60.0%N/A0 $8.47 3/15/2023500 shares $3,810.00 No ChangeN/A0.1 $7.62 2/15/2023100 shares $739.00 -90.0%N/A0 $7.39 1/31/20231,000 shares $7,710.00 No ChangeN/A0.2 $7.71 12/30/2022700 shares $5,624.50 -58.8%N/A0.1 $8.04 12/15/20221,700 shares $13,642.50 -74.6%N/A0.2 $8.03⭕ [URGENT] Buy Alert just triggered (Ad)My absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> 11/30/20226,700 shares $53,600.00 +86.1%N/A0.4 $8.00 11/15/20223,600 shares $27,468.00 +12.5%N/A0.1 $7.63 10/31/20223,200 shares $21,840.00 -94.0%N/A0.1 $6.83 10/15/202253,100 shares $348,336.00 +517.4%N/A0.9 $6.56 9/30/20228,600 shares $58,222.00 +207.1%N/A0.1 $6.77 9/15/20222,800 shares $18,760.00 -85.6%N/A0 $6.70 8/31/202219,500 shares $139,230.00 +236.2%N/A0.3 $7.14 8/15/20225,800 shares $45,396.60 +5,700.0%N/A0.2 $7.83 7/31/2022100 shares $801.50 No ChangeN/A0 $8.02 6/15/2022400 shares $2,916.00 -90.9%N/A0 $7.29 5/31/20224,400 shares $35,310.00 -63.3%N/A0 $8.03 5/15/202212,000 shares $95,520.00 +823.1%N/A0 $7.96 4/30/20221,300 shares $10,517.00 -38.1%N/A0 $8.09 4/15/20222,100 shares $18,270.00 -92.0%N/A0 $8.70 3/31/202226,300 shares $262,474.00 +87.9%N/A0.3 $9.98 3/15/202214,000 shares $152,600.00 -8.5%N/A0.1 $10.90 2/28/202215,300 shares $173,349.00 -26.4%N/A0.1 $11.33 2/15/202220,800 shares $236,496.00 +300.0%N/A0.1 $11.37 1/31/20225,200 shares $58,812.00 +1,200.0%N/A0 $11.31 1/15/2022400 shares $4,864.00 -98.2%N/A0 $12.16 12/31/202121,600 shares $262,980.00 No ChangeN/A0.1 $12.18 11/30/20211,800 shares $23,670.00 -85.9%N/A0 $13.15 11/15/202112,800 shares $178,412.80 +17.4%N/A0.3 $13.94 10/29/202110,900 shares $153,690.00 +10,800.0%N/A0.2 $14.10 10/15/2021100 shares $1,378.00 -98.4%N/A0 $13.78 9/30/20216,400 shares $90,016.00 +52.4%N/A0.2 $14.07 9/15/20214,200 shares $63,798.00 -8.7%N/A0.2 $15.19 8/31/20214,600 shares $69,368.00 -82.4%N/A0 $15.08 8/13/202126,100 shares $389,673.00 -29.3%N/A0.5 $14.93 7/30/202136,900 shares $498,519.00 +738.6%N/A0.6 $13.51 7/15/20214,400 shares $61,908.00 -85.7%N/A0.1 $14.07 6/30/202130,800 shares $425,964.00 -18.5%N/A0.5 $13.83 6/15/202137,800 shares $526,176.00 +384.6%N/A0.3 $13.92 5/28/20217,800 shares $103,896.00 +136.4%N/A0.1 $13.32 5/14/20213,300 shares $44,253.00 -89.2%N/A0 $13.41 4/30/202130,500 shares $393,145.00 -12.6%N/A0.3 $12.89 4/15/202134,900 shares $466,613.00 -44.4%N/A0.2 $13.37 3/31/202162,800 shares $869,780.00 +784.5%N/A0.5 $13.85 3/15/20217,100 shares $96,986.00 -27.6%N/A0.1 $13.66 2/26/20219,800 shares $137,788.00 +38.0%N/A0.1 $14.06 2/12/20217,100 shares $111,399.00 -70.7%N/A0.1 $15.69 1/29/202124,200 shares $400,026.00 +414.9%N/A0.5 $16.53 12/31/202013,200 shares $213,048.00 No ChangeN/A0.2 $16.14 11/30/20203,800 shares $64,284.60 -85.7%N/A0.1 $16.92 11/15/202026,600 shares $434,577.50 +786.7%N/A0.6 $16.34 10/30/20203,000 shares $55,530.00 +66.7%N/A0.2 $18.51 10/15/20201,800 shares $35,928.00 -86.4%N/A0 $19.96 9/30/202013,200 shares $271,260.00 -5.7%N/A1.1 $20.55 9/15/202014,000 shares $276,220.00 +225.6%N/A0.5 $19.73 8/31/20204,300 shares $81,958.00 -76.5%N/A0.2 $19.06Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.Click here for the ticker >>> 8/14/202018,300 shares $342,235.62 +16.6%N/A0.5 $18.70 7/31/202015,700 shares $263,775.70 +31.9%N/A0.5 $16.80 7/15/202011,900 shares $212,534.00 -25.6%N/A0.5 $17.86 6/30/202016,000 shares $294,720.00 +233.3%N/A0.7 $18.42 6/15/20204,800 shares $89,205.60 -65.0%N/A0.2 $18.58 5/29/202013,700 shares $252,011.50 -22.6%N/A0.4 $18.40 5/15/202017,700 shares $313,520.10 +88.3%N/A0.4 $17.71 4/30/20209,400 shares $165,534.00 -40.1%N/A0.1 $17.61 4/15/202015,700 shares $273,337.00 -50.2%N/A0.3 $17.41 3/31/202031,500 shares $535,185.00 +416.4%N/A0.4 $16.99 3/13/20206,100 shares $84,790.00 -72.3%N/A0.1 $13.90 2/28/202022,000 shares $352,660.00 +168.3%N/A0.4 $16.03 2/14/20208,200 shares $130,380.00 -48.4%N/A0.2 $15.90 1/31/202015,900 shares $297,648.00 +169.5%N/A1.5 $18.72 1/15/20205,900 shares $115,728.50 +156.5%N/A0.7 $19.62 12/31/20192,300 shares $44,689.00 +27.8%N/A0.2 $19.43 SNPHY Short Interest - Frequently Asked Questions What is Santen Pharmaceutical's current short interest? Short interest is the volume of Santen Pharmaceutical shares that have been sold short but have not yet been closed out or covered. As of November 30th, traders have sold 100 shares of SNPHY short. Learn More on Santen Pharmaceutical's current short interest. Is Santen Pharmaceutical's short interest increasing or decreasing? Santen Pharmaceutical saw a increase in short interest in the month of November. As of November 30th, there was short interest totaling 100 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Santen Pharmaceutical's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Santen Pharmaceutical: Abliva AB (publ) (0.00%), ADM Tronics Unlimited, Inc. (0.01%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Santen Pharmaceutical stock? Short selling SNPHY is an investing strategy that aims to generate trading profit from Santen Pharmaceutical as its price is falling. SNPHY shares are trading up $0.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Santen Pharmaceutical? A short squeeze for Santen Pharmaceutical occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SNPHY, which in turn drives the price of the stock up even further. How often is Santen Pharmaceutical's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNPHY, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies AstraZeneca Short Interest Daiichi Sankyo Short Interest JCR Pharmaceuticals Short Interest Kyowa Kirin Short Interest Mayne Pharma Group Short Interest Ono Pharmaceutical Short Interest Orion Oyj Short Interest Otsuka Short Interest Otsuka Short Interest Roche Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:SNPHY) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Santen Pharmaceutical Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Santen Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
